Triple
T5873241
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | HMA Multi-Annual Work Plan |
E130566
|
entity |
| Predicate | isApprovedBy |
P807
|
FINISHED |
| Object | Heads of Medicines Agencies |
E23506
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Heads of Medicines Agencies | Statement: [HMA Multi-Annual Work Plan, isApprovedBy, Heads of Medicines Agencies]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Heads of Medicines Agencies Context triple: [HMA Multi-Annual Work Plan, isApprovedBy, Heads of Medicines Agencies]
-
A.
Heads of Medicines Agencies
chosen
Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
-
B.
Executive Director of the European Medicines Agency
The Executive Director of the European Medicines Agency is the chief executive responsible for leading the agency’s operations, implementing its policies, and overseeing the evaluation and supervision of medicines in the European Union.
-
C.
European medicines regulatory authorities
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
D.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
E.
Management Board of the European Medicines Agency
The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0085047dc8190af24e311edad3c07 |
completed | March 22, 2026, 3:18 p.m. |
| NER | Named-entity recognition | batch_69c035f99b788190b5b06d83b9499bfa |
completed | March 22, 2026, 6:33 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c0e377e1108190b0820f92eab012c2 |
completed | March 23, 2026, 6:53 a.m. |
Created at: March 22, 2026, 3:56 p.m.